Do antipsychotics increase diabetes risk in children and adolescents?
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Do antipsychotics increase diabetes risk in children and adolescents?
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 14, Issue 2, Pages 219-241
Publisher
Informa Healthcare
Online
2014-12-06
DOI
10.1517/14740338.2015.979150
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased Prevalence of Obesity and Glucose Intolerance in Youth Treated with Second—Generation Antipsychotic Medications
- (2017) Constadina Panagiotopoulos et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Waist Circumference is a Sensitive Screening Tool for Assessment of Metabolic Syndrome Risk in Children Treated with Second-Generation Antipsychotics
- (2017) Constadina Panagiotopoulos et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Adverse Events Associated With Psychotropic Treatment in African American Children and Adolescents
- (2015) Jeanette M. Jerrell JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
- Cardiometabolic Outcomes in Children and Adolescents Following Discontinuation of Long-Term Risperidone Treatment
- (2014) Chadi A. Calarge et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Quetiapine Treatment in Youth Is Associated With Decreased Insulin Secretion
- (2014) Ying Fai Ngai et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Treatment of adolescents with early-onset schizophrenia spectrum disorders
- (2013) Benno G. Schimmelmann et al. CURRENT OPINION IN PSYCHIATRY
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
- (2013) Stefan Leucht et al. LANCET
- Pharmacoepidemiology of Antipsychotic Use in Youth with ADHD: Trends and Clinical Implications
- (2013) Michael L. Birnbaum et al. Current Psychiatry Reports
- Antipsychotics and the Risk of Type 2 Diabetes Mellitus in Children and Youth
- (2013) William V. Bobo et al. JAMA Psychiatry
- National Trends in the Office-Based Treatment of Children, Adolescents, and Adults With Antipsychotics
- (2012) Mark Olfson et al. ARCHIVES OF GENERAL PSYCHIATRY
- Metabolic Screening in Children Receiving Antipsychotic Drug Treatment
- (2012) Elaine H. Morrato et al. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE
- Comparison of Long-Term (At Least 24 Weeks) Weight Gain and Metabolic Changes Between Adolescents and Adults Treated with Olanzapine
- (2012) Ludmila A. Kryzhanovskaya et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Acute and maintenance effects of non-pharmacologic interventions for antipsychotic associated weight gain and metabolic abnormalities: A meta-analytic comparison of randomized controlled trials
- (2012) Jacqueline Caemmerer et al. SCHIZOPHRENIA RESEARCH
- Systematic Review of Early Cardiometabolic Outcomes of the First Treated Episode of Psychosis
- (2011) Debra L. Foley et al. ARCHIVES OF GENERAL PSYCHIATRY
- Metabolic and Neurological Complications of Second-Generation Antipsychotic Use in Children
- (2011) Tamara Pringsheim et al. DRUG SAFETY
- Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: A review of the randomized controlled studies
- (2011) Alessandro Zuddas et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice
- (2011) M. De Hert et al. EUROPEAN PSYCHIATRY
- No Unexpected Adverse Events and Biochemical Side Effects of Olanzapine as Adjunct Treatment in Adolescent Girls with Eating Disorders
- (2011) Ingemar Swenne et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Weight Gain and Metabolic Risks Associated with Antipsychotic Medications in Children and Adolescents
- (2011) Lawrence Maayan et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Safety and Tolerability of Antipsychotic Treatment in Young Patients With Schizophrenia
- (2011) Christoph U. Correll JOURNAL OF CLINICAL PSYCHIATRY
- Safety and Tolerability of Aripiprazole for Irritability in Pediatric Patients With Autistic Disorder
- (2011) Ronald N. Marcus et al. JOURNAL OF CLINICAL PSYCHIATRY
- Developments in Pediatric Psychopharmacology
- (2011) Christoph U. Correll et al. JOURNAL OF CLINICAL PSYCHIATRY
- Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
- (2011) Marc De Hert et al. Nature Reviews Endocrinology
- Adolescent BMI Trajectory and Risk of Diabetes versus Coronary Disease
- (2011) Amir Tirosh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antipsychotic Medication Use Among Children and Risk of Diabetes Mellitus
- (2011) S. E. Andrade et al. PEDIATRICS
- Increasing off-label use of antipsychotic medications in the United States, 1995-2008
- (2011) G. C. Alexander et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials
- (2010) Christoph U Correll et al. BIPOLAR DISORDERS
- Treatment with antipsychotics and the risk of diabetes in clinical practice
- (2010) Lars Vedel Kessing et al. BRITISH JOURNAL OF PSYCHIATRY
- Obesity and coronary risk in patients treated with second-generation antipsychotics
- (2010) Christoph U. Correll et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: Comprehensive review of prospective head-to-head and placebo-controlled comparisons
- (2010) David Fraguas et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Management of antipsychotic-related weight gain
- (2010) Lawrence Maayan et al. Expert Review of Neurotherapeutics
- Age-Dependent Metabolic Effects of Second-Generation Antipsychotics in Second-Generation Antipsychotic-Naïve French Canadian Patients
- (2010) Geneviève Roy et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naïve Schizophrenia Patients
- (2010) Jimmi Nielsen et al. NEUROPSYCHOPHARMACOLOGY
- Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis
- (2010) Christine Rummel-Kluge et al. SCHIZOPHRENIA RESEARCH
- Antipsychotic drugs and obesity
- (2010) Christoph U. Correll et al. TRENDS IN MOLECULAR MEDICINE
- Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study
- (2009) Magali Haas et al. BIPOLAR DISORDERS
- Broadened Use Of Atypical Antipsychotics: Safety, Effectiveness, And Policy Challenges
- (2009) Stephen Crystal et al. HEALTH AFFAIRS
- Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
- (2009) Christoph U. Correll JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Naturalistic Study of Predictors and Risks of Atypical Antipsychotic Use in an Attention-Deficit/Hyperactivity Disorder Clinic
- (2009) Margaret Weiss et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Metabolic and Hormonal Side Effects in Children and Adolescents Treated With Second-Generation Antipsychotics
- (2009) David Fraguas et al. JOURNAL OF CLINICAL PSYCHIATRY
- Acute Treatment of Pediatric Bipolar I Disorder, Manic or Mixed Episode, With Aripiprazole
- (2009) Robert L. Findling et al. JOURNAL OF CLINICAL PSYCHIATRY
- Antipsychotic Use in Children and Adolescents: Minimizing Adverse Effects to Maximize Outcomes
- (2009) CHRISTOPH U. CORRELL et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- The incidence of diabetes in atypical antipsychotic users differs according to agent-results from a multisite epidemiologic study
- (2009) Marianne Ulcickas Yood et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Double-Blind Comparison of First- and Second-Generation Antipsychotics in Early-Onset Schizophrenia and Schizo-affective Disorder: Findings From the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) Study
- (2008) Linmarie Sikich et al. AMERICAN JOURNAL OF PSYCHIATRY
- A Multiple-Center, Randomized, Double-Blind, Placebo-Controlled Study of Oral Aripiprazole for Treatment of Adolescents With Schizophrenia
- (2008) Robert L. Findling et al. AMERICAN JOURNAL OF PSYCHIATRY
- A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia
- (2008) Stefan Leucht et al. AMERICAN JOURNAL OF PSYCHIATRY
- Antipsychotics and Diabetes: An Age-Related Association
- (2008) Ariel Hammerman et al. ANNALS OF PHARMACOTHERAPY
- Metabolic and Cardiovascular Adverse Events Associated With Antipsychotic Treatment in Children and Adolescents
- (2008) Roger S. McIntyre et al. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE
- First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: Systematic review and meta-analysis
- (2008) M. Smith et al. BRITISH JOURNAL OF PSYCHIATRY
- Tolerability of Oral Ziprasidone in Children and Adolescents with Bipolar Mania, Schizophrenia, or Schizoaffective Disorder
- (2008) Melissa P. DelBello et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now